Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07288827 · ClinicalTrials.gov registry record · NA
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
A NA study of Healthy and Primary Ciliary Dyskinesia, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07288827: Recruiting NA study of Healthy and Primary Ciliary Dyskinesia, sponsored by Indiana University.
NCT07288827 is a NA study of Healthy and Primary Ciliary Dyskinesia that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07288827, a NA study of Healthy and Primary Ciliary Dyskinesia, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at children with PCD and see if they have another condition called "bronchial hyperresponsiveness".
Primary Outcome
Examine how many subjects with PCD have bronchial hyperresponsiveness as evidenced by an increase in FEV1 of 10% or greater during pre- and post- max bronchodilator test.
Conditions Studied
Interventions
- PROCEDURE Lung Function Testing
- PROCEDURE Phlebotomy
- PROCEDURE Allergy skin prick testing
- PROCEDURE Methacholine Challenge
Study Locations (1)
Indiana
- Riley Hospital for Children - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What NCT07288827 shows while recruiting
NCT07288827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Lung Function Testing is the first listed.
NCT07288827 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07288827 about?
NCT07288827 is a clinical study titled "Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia". The purpose of this study is to look at children with PCD and see if they have another condition called "bronchial hyperresponsiveness".
What is the current status of trial NCT07288827?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-04. Estimated completion is 2028-04-30.
What conditions does trial NCT07288827 study?
This clinical trial studies the following conditions: Healthy, Primary Ciliary Dyskinesia.
What interventions are being tested in trial NCT07288827?
The interventions under investigation include: Lung Function Testing (PROCEDURE), Phlebotomy (PROCEDURE), Allergy skin prick testing (PROCEDURE), Methacholine Challenge (PROCEDURE).
Who is sponsoring clinical trial NCT07288827?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07288827 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07288827's enrollment target sits among peer trials
40 540th of 1090 higher than 513 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI